SpyLigation Uses Light to Switch on Proteins
April 17, 2023 | Categories: Core Faculty, Research |Light-activation technology developed by the Cole DeForest Research Group has potential applications in tissue engineering, regenerative medicine, and understanding how the body works. Read More
Two ISCRM Trainees Named to 2021 Husky 100 List
June 14, 2021 | Categories: Award |ISCRM trainees Eric Scott Nealy, PhD and Kendan Jones-Isaac have been recognized for their contributions to cancer and kidney research. Read More
DeForest Lab Pioneers 4D Biomimicry Systems With Ingenuity, Collaboration, and an NIH Grant
October 1, 2020 | Categories: Award, Core Faculty, Uncategorized |In reality show terms, Cole DeForest and his team manufacture tiny bio-worlds staged to mimic living systems, force an eclectic cast of cells to cohabitate, apply light, heat, and chemicals to stir up drama, then record it all with sophisticated monitoring equipment. What they see on the tiniest scales, could have major implications for medicine. Read More
Improving Islet Transplantation to Treat Type 1 Diabetes
June 22, 2020 | Categories: Award |A major grant from the NIH will allow three ISCRM investigators to use their combined expertise in islet and stem cell biology, vascular biology and cellular immunology, and biomaterials to significantly improve the wellbeing of people with type 1 diabetes. Read More
ISCRM Faculty Shine a New Light on Scarring
October 12, 2018 | Categories: Research |Collaboration is the engine of scientific progress at UW Medicine and at the Institute of Stem Cell & Regenerative Medicine (ISCRM), where 130 researchers are developing stem cell-based approaches to treat diseases affecting nearly every organ and system in the human body. Read More
Researchers program biomaterials with ‘logic gates’ that release therapeutics in response to environmental triggers
January 16, 2018 | Categories: Research |Drug treatments can save lives, but sometimes they also carry unintended costs. After all, the same therapeutics that target pathogens and tumors can also harm healthy cells. To reduce this collateral damage, scientists have long sought specificity in drug delivery systems: A package that can encase a therapeutic and will not disgorge its toxic cargo until it reaches the site of treatment — be it a tumor, a diseased organ or a site of infection. Read More
Network of synthetic blood microvessels built
October 4, 2017 | Categories: Research |Researchers are reporting significant progress in generating a 3-dimensional network of blood vessels that can be grown and manipulated in a laboratory. Building vascular support for stem-cell repaired tissues or replacement organs will be vital to such regenerative therapies. Read More
ISCRM faculty to receive UW Awards of Excellence
May 24, 2016 | Categories: Announcements |ISCRM is pleased to share that Dr. Cole DeForest will receive a Distinguished Teaching Award and Dr. Norm Beauchamp will receive the David B. Thorud Leadership Award at the 46th Annual Awards of […] Read More